Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma
出版年份 2016 全文链接
标题
Efficacy and Safety of Benralizumab, a Monoclonal Antibody against IL-5Rα, in Uncontrolled Eosinophilic Asthma
作者
关键词
-
出版物
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 35, Issue 4, Pages 294-311
出版商
Informa UK Limited
发表日期
2016-04-28
DOI
10.3109/08830185.2015.1128901
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma
- (2015) Richard M. Nowak et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Getting Control of Uncontrolled Asthma
- (2014) Michael E. Wechsler AMERICAN JOURNAL OF MEDICINE
- Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
- (2014) M. Bafadhel et al. EUROPEAN RESPIRATORY JOURNAL
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study
- (2014) Christopher E Brightling et al. Lancet Respiratory Medicine
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
- (2014) Mario Castro et al. Lancet Respiratory Medicine
- Monoclonal antibodies for the treatment of refractory asthma
- (2013) Nathan Hambly et al. CURRENT OPINION IN PULMONARY MEDICINE
- Eosinophilic asthma: Insights into the effects of reducing IL-5 receptor–positive cell levels
- (2013) Amal H. Assa'ad et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
- (2013) Michel Laviolette et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease
- (2012) Mona Bafadhel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Global asthma prevalence in adults: findings from the cross-sectional world health survey
- (2012) Teresa To et al. BMC PUBLIC HEALTH
- Pathogenesis of severe asthma
- (2012) A. H. Poon et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis
- (2011) Todd M. Wilson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Magnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients
- (2010) Federico L. Dente et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Respuesta inflamatoria de la exacerbación asmática de instauración rápida
- (2010) Jesús Bellido-Casado et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro
- (2010) P.-C. TAI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti–IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
- (2010) William W. Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples
- (2010) Mohammed T. Al-Samri et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
- (2010) Roland Kolbeck et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
- (2009) Prescott G. Woodruff et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoregulatory roles of eosinophils: a new look at a familiar cell
- (2008) P. Akuthota et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Eosinophils: Biological Properties and Role in Health and Disease
- (2008) SIMON P. HOGAN et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels
- (2008) Miguel L. Stein et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The cytokine network in asthma and chronic obstructive pulmonary disease
- (2008) Peter J. Barnes JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now